The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging
Abstract
Nephrogenic systemic fibrosis is a new, rare disease of unknown cause that affects patients with renal failure. Single cases led to the suspicion of a causative role of gadodiamide that is used for magnetic resonance imaging. This study therefore reviewed all of the authors' confirmed cases of nephrogenic systemic fibrosis (n = 13) with respect to clinical characteristics, gadodiamide exposure, and subsequent clinical course. It was found that all had been exposed to gadodiamide before the development of nephrogenic systemic fibrosis. The delay from exposure to first sign of the disease was 2 to 75 d (median 25 d). Odds ratio for acquiring the disease when gadodiamide exposed was 32.5 (95% confidence interval 1.9 to 549.2; P < 0.0001). Seven (54%) patients became severely disabled, and one died 21 mo after exposure. No other exposure/event than gadodiamide that was common to more than a minority of the patients could be identified. These findings indicate that gadodiamide plays a causative role in nephrogenic systemic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Nephrogenic Fibrosing Dermopathy
Cowper, S. E., Su, L. D., Bhawan, J., Robin, H. S., & LeBoit, P. E. (2001) · The American Journal of Dermatopathology · doi:10.1097/00000372-200110000-00001 · Cited by 475
White, G. W., Gibby, W. A., & Tweedle, M. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186569.32408.95 · Cited by 362
Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature
Mendoza, F. A., Artlett, C. M., Sandorfi, N., Latinis, K., Piera-Velazquez, S., & Jimenez, S. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.08.002 · Cited by 262
Gilliet, M. F., Cozzio, A., Burg, G., & Nestle, F. O. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06434.x · Cited by 121
WAGONER, M. V., & Worah, D. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00005 · Cited by 54
Cited by
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,018
Diffusion-weighted MR Imaging of the Liver
Taouli, B., & Koh, D.-M. (2010) · Radiology · doi:10.1148/radiol.09090021 · Cited by 810
ACR Guidance Document for Safe MR Practices: 2007
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gilk, T., Gimbel, J. R., Gosbee, J., Kuhni-Kaminski, E., et al. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1616 · Cited by 787
Graphene Quantum Dots and Their Applications in Bioimaging, Biosensing, and Therapy
Chung, S., Revia, R. A., & Zhang, M. (2021) · Advanced Materials · doi:10.1002/adma.201904362 · Cited by 739
Detection of Myocardial Damage in Patients With Sarcoidosis
Patel, M. R., Cawley, P. J., Heitner, J. F., Klem, I., Parker, M. A., Jaroudi, W. A., Meine, T. J., White, J. B., Elliott, M. D., Kim, H. W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.851352 · Cited by 719
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
Davenport, M. S., Perazella, M. A., Yee, J., Dillman, J. R., Fine, D., McDonald, R. J., Rodby, R. A., Wang, C. L., & Weinreb, J. C. (2020) · Radiology · doi:10.1148/radiol.2019192094 · Cited by 601
Sidawy, A. N., Spergel, L. M., Besarab, A., Allon, M., Jennings, W. C., Padberg, F. T., Murad, M. H., Montori, V. M., O'Hare, A. M., Calligaro, K. D., et al. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.08.042 · Cited by 553
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., Chandler, J., Zito, G., & Cowper, S. E. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 545
Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C
Frenzel, T., Lengsfeld, P., Schirmer, H., Hütter, J., & Weinmann, H.-J. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181852171 · Cited by 539
Gadolinium(iii) complexes as MRI contrast agents: ligand design and properties of the complexes
Hermann, P., Kotek, J., Kubíček, V., & Lukeš, I. (2008) · Dalton Transactions · doi:10.1039/b719704g · Cited by 530
Dai, C., Chen, Y., Jing, X., Xiang, L., Yang, D., Lin, H., Liu, Z., Han, X., & Wu, R. (2017) · ACS Nano · doi:10.1021/acsnano.7b07241 · Cited by 520
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
Ramalho, J., Semelka, R. C., Ramalho, M., Nunes, R. H., AlObaidy, M., & Castillo, M. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4615 · Cited by 453
Thomsen, H. S., Morcos, S. K., Almén, T., Bellin, M.-F., Bertolotto, M., Bongartz, G., Clement, O., Leander, P., Heinz-Peer, G., Reimer, P., et al. (2013) · European Radiology · doi:10.1007/s00330-012-2597-9 · Cited by 441
Self-citationMurata, N., Gonzalez-Cuyar, L. F., Murata, K., Fligner, C., Dills, R., Hippe, D., & Maravilla, K. R. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000252 · Cited by 408
Gadolinium‐based contrast agents: A comprehensive risk assessment
Fraum, T. J., Ludwig, D. R., Bashir, M. R., & Fowler, K. J. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25625 · Cited by 402
Idée, J., Port, M., Raynal, I., Schaefer, M., Le Greneur, S., & Corot, C. (2006) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00447.x · Cited by 395
Gadolinium deposition in nephrogenic fibrosing dermopathy
Boyd, A. S., Zic, J. A., & Abraham, J. L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.048 · Cited by 373
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 371
Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy
Hu, Y., Mignani, S., Majoral, J.-P., Shen, M., & Shi, X. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00657h · Cited by 370
A Manganese Alternative to Gadolinium for MRI Contrast
Gale, E. M., Atanasova, I. P., Blasi, F., Ay, I., & Caravan, P. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10748 · Cited by 353
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Self-citationWhat nephrologists need to know about gadolinium
Penfield, J. G., & Reilly, R. F. (2007) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0660 · Cited by 335
Elemental and Chemically Specific X-ray Fluorescence Imaging of Biological Systems
Pushie, M. J., Pickering, I. J., Korbas, M., Hackett, M. J., & George, G. N. (2014) · Chemical Reviews · doi:10.1021/cr4007297 · Cited by 332
Klem, I., Weinsaft, J. W., Bahnson, T. D., Hegland, D., Kim, H. W., Hayes, B., Parker, M. A., Judd, R. M., & Kim, R. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.070 · Cited by 331
Collidge, T. A., Thomson, P. C., Mark, P. B., Traynor, J. P., Jardine, A. G., Morris, S. T. W., Simpson, K., & Roditi, G. H. (2007) · Radiology · doi:10.1148/radiol.2451070353 · Cited by 319
The Pathogenesis of Systemic Sclerosis
Katsumoto, T. R., Whitfield, M. L., & Connolly, M. K. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130312 · Cited by 313
Dillman, J. R., Ellis, J. H., Cohan, R. H., Strouse, P. J., & Jan, S. C. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2554 · Cited by 303
Incorporation of excess gadolinium into human bone from medical contrast agents
Darrah, T. H., Prutsman-Pfeiffer, J. J., Poreda, R. J., Ellen Campbell, M., Hauschka, P. V., & Hannigan, R. E. (2009) · Metallomics · doi:10.1039/b905145g · Cited by 299
Renovascular Hypertension and Ischemic Nephropathy
Garovic, V. D., & Textor, S. C. (2005) · Circulation · doi:10.1161/circulationaha.104.492348 · Cited by 296
Gadolinium and nephrogenic systemic fibrosis
Grobner, T., & Prischl, F. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002338 · Cited by 293
Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
Prince, M. R., Zhang, H., Morris, M., MacGregor, J. L., Grossman, M. E., Silberzweig, J., DeLapaz, R. L., Lee, H. J., Magro, C. M., & Valeri, A. M. (2008) · Radiology · doi:10.1148/radiol.2483071863 · Cited by 290
Ersoy, H., & Rybicki, F. J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21135 · Cited by 283
Broome, D. R. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.011 · Cited by 283
Current status of gadolinium toxicity in patients with kidney disease
Perazella, M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06011108 · Cited by 275
Deo, A., Fogel, M., & Cowper, S. E. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03921106 · Cited by 259
MR contrast agents: Physical and pharmacologic basics
Lin, S., & Brown, J. J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20955 · Cited by 259
Li, R., Ji, Z., Chang, C. H., Dunphy, D. R., Cai, X., Meng, H., Zhang, H., Sun, B., Wang, X., Dong, J., et al. (2014) · ACS Nano · doi:10.1021/nn406166n · Cited by 255
Rydahl, C., Thomsen, H. S., & Marckmann, P. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31815a3407 · Cited by 252
Self-citationGadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution
Do, C., DeAguero, J., Brearley, A., Trejo, X., Howard, T., Escobar, G. P., & Wagner, B. (2020) · Kidney360 · doi:10.34067/kid.0000272019 · Cited by 125
Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention
Safley, D. M., Salisbury, A. C., Tsai, T. T., Secemsky, E. A., Kennedy, K. F., Rogers, R. K., Latif, F., Shammas, N. W., Garcia, L., Cavender, M. A., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.10.028 · Cited by 20
Metadata
- Authors
- Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-09
- Volume
- 17
- Issue
- 9
- Pages
- 2359-2362
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2157433411
- Cited by
- 1,400
- References
- 6
- FWCI
- 83.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.